The Board of Directors of Aurinia Pharmaceuticals Inc. has authorized a buyback plan on February 15, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.91 USD | +0.82% | -1.60% | -45.38% |
Mar. 20 | ILJIN SNT Delivers a Letter to Aurinia Pharmaceuticals | CI |
Mar. 07 | Aurinia Pharmaceuticals Insider Sold Shares Worth $711,094, According to a Recent SEC Filing | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-45.38% | 710M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- AUPH Stock
- News Aurinia Pharmaceuticals Inc.
- Aurinia Pharmaceuticals Inc. authorizes a Buyback Plan.